David W Ollila

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Neoadjuvant Chemotherapy

Top Venues

NPJ breast cancer

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Selena J An, Emilie D Duchesneau, Paula D Strassle, Katherine Reeder-Hayes, Kristalyn K Gallagher, David W Ollila, Stephanie M Downs-Canner, Philip M Spanheimer
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer. NPJ breast cancer 8 (1) (2022)
Kathleen A Iles, Mya L Roberson, Philip M Spanheimer, Kristalyn K Gallagher, David W Ollila, Paula D Strassle, Stephanie M Downs-Canner
The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. NPJ breast cancer 8 (1) (2022)
Danielle R Davari, Irene Orlow, Peter A Kanetsky, Li Luo, Sharon N Edmiston, Kathleen Conway, Eloise A Parrish, Honglin Hao, Klaus J Busam, Ajay Sharma, Anne Kricker, Amelia K Smit, Hoda Anton-Culver, Stephen B Gruber, Richard P Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David W Ollila, Colin B Begg, Marianne Berwick, Nancy E Thomas, null null
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (12) (2021)